相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Do current clinical trials in cystic fibrosis match the priorities of patients and clinicans? A systematic review
I. S. Kalaitzis et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Finding the relevance of antimicrobial stewardship for cystic fibrosis
Jonathan D. Cogen et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review
Ranjani Somayaji et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections
Valerie J. Waters et al.
CLINICAL INFECTIOUS DISEASES (2019)
Patient engagement to prioritise CF research: Inclusive or selective?
Nicola J. Rowbotham et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
Beyond the expected: Identifying broad research priorities of researchers and the cystic fibrosis community
I. L. Hollin et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers
Nicola J. Rowbotham et al.
THORAX (2018)
Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CF
Sonya L. Heltshe et al.
CONTEMPORARY CLINICAL TRIALS (2018)
Defining antimicrobial resistance in cystic fibrosis
Timothy J. Kidd et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
Antimicrobial resistance in cystic fibrosis: Does it matter?
Patrick A. Flume et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial
Marianne Sponer Muhlebach et al.
THORAX (2017)
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations
Natalie E. West et al.
JOURNAL OF CYSTIC FIBROSIS (2017)
Treatment decisions for MRSA in patients with cystic fibrosis (CF): when is enough, enough?
Scott C. Bell et al.
THORAX (2017)
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
Tamar F. Barlam et al.
CLINICAL INFECTIOUS DISEASES (2016)
Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients
Yvonne C. W. Yau et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update
Lisa Saiman et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2014)
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
Gerd Doering et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
M. N. Hurley et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Association Between Respiratory Tract Methicillin-Resistant Staphylococcus aureus and Survival in Cystic Fibrosis
Elliott C. Dasenbrook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Azithromycin in, patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa -: A randomized controlled trial
L Saiman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Factors influencing outcomes in cystic fibrosis - A center-based analysis
C Johnson et al.
CHEST (2003)
Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis
SD Aaron et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
分享论文
